Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease

Pontone, Gregory M., Williams, James R., Anderson, Karen E., Chase, Gary, Goldstein, Susanne A., Grill, Stephen, Hirsch, Elaina S., Lehmann, Susan +5 more·2009·Movement Disorders
DOI 10.1002/mds.22611

Cited by (303)

Items 101–200 of 303

  1. Evaluation and management of the non-motor features of Parkinson’s disease
    Steven Wishart, Graeme J.A. Macphee · 2010 · Therapeutic Advances in Chronic Disease
  2. Altered putamen functional connectivity is associated with anxiety disorder in Parkinson's disease
    Xixi Wang, Junyi Li, Yongsheng Yuan, Min Wang, Jian Ding, Jiejin Zhang, Lin Zhu, Yuting Shen, Hui Zhang, Kezhong Zhang · 2017 · Oncotarget
  3. Sleep deprivation caused a memory defects and emotional changes in a rotenone-based zebrafish model of Parkinson’s disease
    Dong-Jun Lv, Li Lingxi, Jing Chen, Shizhuang Wei, Fen Wang, Hua Hu, Anmu Xie, Chun‐Feng Liu · 2019 · Behavioural Brain Research
  4. Nonmotor Symptoms in Parkinson's Disease
    U. Akbar, A. D'Abreu, J. Friedman · 2017 · Seminars in neurology
  5. Sensory focused exercise improves anxiety in Parkinson’s disease: A randomized controlled trial
    Eric N. Beck, Mary T. Y. Wang, Brittany Intzandt, Quincy J. Almeida, Kaylena A. Ehgoetz Martens · 2020 · PLoS ONE
  6. Management of anxiety and motor symptoms in Parkinson’s disease
    Sarah Coakeley, Kaylena A. Ehgoetz Martens, Quincy J. Almeida · 2014 · Expert Review of Neurotherapeutics
  7. Understanding, Impact, and Communication of “Off” Periods in Parkinson's Disease: A Scoping Review
    Tara Rastgardani, Melissa J. Armstrong, Anna R. Gagliardi, Connie Marras · 2018 · Movement Disorders Clinical Practice
  8. The impact of iron deposition on the fear circuit of the brain in patients with Parkinson’s disease and anxiety
    Kaidong Chen, Li Zhang, Haixia Mao, Kefei Chen, Yachen Shi, Xiangpan Meng, Feng Wang, Xiaoyun Hu, Xiangming Fang · 2023 · Frontiers in Aging Neuroscience
  9. Clinical Presentation of Anxiety in Parkinson’s Disease
    Sara G Lutz, Jeffrey D. Holmes, Emily A. Ready, Mary E. Jenkins, Andrew M. Johnson · 2016 · OTJR Occupational Therapy Journal of Research
  10. Complex Dynamics in the Basal Ganglia: Health and Disease Beyond the Motor System
    Daniela Sabrina Andrés, Olivier Darbin · 2017 · Journal of Neuropsychiatry
  11. Phenomenology of Atypical Anxiety Disorders in Parkinson's Disease: A Systematic Review
    Nadeeka N. Dissanayaka, Elana J. Forbes, Kate M. Perepezko, Albert F.G. Leentjens, Roseanne D. Dobkin, Kathy Dujardin, Gregory M. Pontone · 2022 · American Journal of Geriatric Psychiatry
  12. The Association Between Freezing of gait, Fear of Falling and Anxiety in Parkinson’s Disease: A Longitudinal Analysis
    Ires Ghielen, Perrie Koene, Jos W. R. Twisk, Gert Kwakkel, Odile A. van den Heuvel, Erwin E. H. van Wegen · 2020 · Neurodegenerative Disease Management
  13. A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s disease
    Jacob D. Jones, Brandon Dominguez, Joseph Bunch, Carmen Uribe, Yenny Valenzuela, Jonathan P. Jacobs · 2021 · Clinical Parkinsonism & Related Disorders
  14. Designing a new scale to measure anxiety symptoms in P arkinson's disease: item selection based on canonical correlation analysis
    Pablo Martínez‐Martín, José Manuel Rojo-Abuín, Kathy Dujardin, Gregory M. Pontone, Daniel A. Weintraub, Maria João Forjaz, SERGIO E. STARKSTEIN, Albert F.G. Leentjens · 2013 · European Journal of Neurology
  15. “Pseudo-syndromes” associated with Parkinson disease, dementia, apathy, anxiety, and depression
    Weiss, Howard D., Pontone, Gregory M. · 2019 · Neurology Clinical Practice
  16. The Relationship Between Anxiety Disorders and Parkinson’s Disease: Clinical and Therapeutic Issues
    Sandra Abou Kassm, Wadih Naja, Ramzi S. Haddad, Antoine Pélissolo · 2021 · Current Psychiatry Reports
  17. Cognitive Behavioral Therapy: Principles, Science, and Patient Selection in Neurology
    Alan J Carson, Laura McWhirter · 2022 · Seminars in Neurology
  18. SPECIFYING CHILD ANXIETY DISORDERS NOT OTHERWISE SPECIFIED IN THE DSM-IV
    Jonathan S. Comer, Kaitlin P. Gallo, Priya A. Korathu-Larson, Donna B. Pincus, Timothy A. Brown · 2012 · Depression and Anxiety
  19. Advances in the study of depression and anxiety in Parkinson’s disease: A review
    Zhonglong Wang, Hongkai Wei, Yanhong Xin, Wei Qin · 2025 · Medicine
  20. Defining Atypical Anxiety in Parkinson's Disease
    Elana J. Forbes, Gerard J. Byrne, John D. O’Sullivan, Jihyun Yang, Rodney Marsh, Nadeeka N. Dissanayaka · 2021 · Movement Disorders Clinical Practice
  21. Driving and dementia: a clinician's guide
    Sarah Wilson, Gill Pinner · 2013 · Advances in Psychiatric Treatment
  22. Nonpharmacologic Interventions for the Self-Management of Anxiety in Parkinson’s Disease: A Comprehensive Review
    Susan K. Chandler, Jo Lynne W. Robins, Patricia Anne Kinser · 2019 · Behavioural Neurology
  23. Restless leg syndrome: a risk factor of higher prevalence of anxiety and depression in Parkinson’s disease patients
    Abdul Qayyum Rana, Abdullah Mosabbir, Abdul Rehman Qureshi, Muhammad Abbas, Mohammad Abdullah Rana · 2016 · Neurological Research
  24. Psychiatric Conditions in Parkinson Disease
    Massimiliano Buoli, Alice Caldiroli, Alfredo Carlo Altamura · 2015 · Journal of Geriatric Psychiatry and Neurology
  25. Home-Based Walking Meditation Decreases Disease Severity in Parkinson's Disease: A Randomized Controlled Trial
    Witoon Mitarnun, Witid Mitranun, Wenika Mitarnun, Wilasinee Pangwong · 2022 · Journal of Integrative and Complementary Medicine
  26. Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity
    Anne E.P. Mulders, Anja J.H. Moonen, Kathy Dujardin, Mark L. Kuijf, Annelien Duits, Bérengère Flinois, Ron L. H. Handels, Renaud Lopes, Albert F.G. Leentjens · 2018 · Journal of Psychosomatic Research
  27. Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease
    Camilla Elefante, Giulio Emilio Brancati, Silvia Bacciardi, Sonia Mazzucchi, Eleonora Del Prete, Giovanni Palermo, Daniela Frosini, Ubaldo Bonuccelli, Roberto Ceravolo, Lorenzo Lattanzi et al. · 2021 · Journal of Clinical Medicine
  28. A latent class analysis of psychological disturbance in Parkinson's disease
    Laura B. Zahodne, Michael Marsiske, Dawn Bowers · 2013 · International Journal of Geriatric Psychiatry
  29. Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways
    Jihu Zhao, Huafang Jia, Pengju Ma, Da Yuan Zhu, Yibin Fang · 2025 · Pharmacological Research
  30. Odorants: a tool to provide nonpharmacological intervention to reduce anxiety during normal and pathological aging
    Bénédicte Ballanger, Kevin G. Bath, Nathalie Mandairon · 2019 · Neurobiology of Aging
  31. Influence of Disease Severity on Fatigue in Patients with Parkinson's Disease Is Mainly Mediated by Symptoms of Depression
    Jitse Pieter van Dijk, Eva Havlíková, Jaroslav Rosenberger, Iveta Nagyová, Matěj Škorvánek, Zuzana Gdovinová, Willem Lok, Johan W. Groothoff, Berrie Middel · 2013 · European Neurology
  32. REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effects
    Ana Carolina D. Noseda, Adriano Targa, Laís Soares Rodrigues, Mariana F. Aurich, Marcelo M. S. Lima · 2015 · Sleep Science
  33. Online Mindfulness-Based Cognitive Therapy for People with Parkinson’s Disease and Their Caregivers: a Pilot Study
    Seritan, Andreea L., Iosif, Ana-Maria, Prakash, Prarthana, Wang, Sarah S., Eisendrath, Stuart · 2022 · Journal of Technology in Behavioral Science
  34. Motor and non-motor fluctuations in Parkinson’s disease: the knowns and unknowns of current therapeutic approaches
    Martin Regensburger, Ilona Csóti, Wolfgang H. Jost, Zacharias Kohl, Stefan Lorenzl, David José Pedrosa, Paul Lingor · 2025 · Journal of Neural Transmission
  35. The Effect of SSRIs on the Binding of 18F-FP-CIT in Parkinson Patients: A Retrospective Case Control Study
    Minjung Seo, Minyoung Oh, Minjung Cho, Sun Ju Chung, Chong Sik Lee, Jae Seung Kim · 2014 · Nuclear Medicine and Molecular Imaging
  36. Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson’s disease
    Xiu-Lin Liu, Shuying Liu, Olivier Barret, Gilles D. Tamagnan, Hongwen Qiao, Tian-Bin Song, Jie Lu, Piu Chan · 2022 · Frontiers in Aging Neuroscience
  37. What is the lived experience of anxiety for people with Parkinson’s? A phenomenological study
    Lovegrove, Christopher J., Bannigan, Katrina · 2021 · PLOS ONE
  38. The prevalence of psychiatric symptoms before the diagnosis of Parkinson’s disease in a nationwide cohort: A comparison to patients with cerebral infarction
    Szabolcs Szatmári, András Ajtay, Ferenc Oberfrank, Balázs Dobi, Dániel Bereczki · 2020 · PLoS ONE
  39. Evaluating the Link Between Dopaminergic Treatment, Gait Impairment, and Anxiety in Parkinson's Disease
    Kaylena A. Ehgoetz Martens, Colin G. Ellard, Quincy J. Almeida · 2016 · Movement Disorders Clinical Practice
  40. Depression and associated factors in nondemented Chinese patients with Parkinson’s disease
    Jun Zhu, Liyu Lu, Yang Pan, Bo Shen, Shulan Xu, Yu‐Chao Hou, Xiangrong Zhang, Li Zhang · 2017 · Clinical Neurology and Neurosurgery
  41. A pilot study to determine the psychological effects of manipulation of therapeutic art forms among patients with Parkinson's disease
    Deborah L. Elkis-Abuhoff, Robert B. Goldblatt, Morgan Gaydos, Caitlin A Convery · 2013 · International Journal of Art Therapy
  42. Motion and emotion: anxiety–axial connections in Parkinson’s disease
    Rastislav Šumec, Irena Rektorová, Robert Jech, Kateřina Menšíková, Jan Roth, Evžen Růžička, Dana Sochorová, Ladislav Dušek, Petr Kaňovský, Ivan Rektor et al. · 2016 · Journal of Neural Transmission
  43. Effects of Gut Microbiota Alterations on Motor, Gastrointestinal, and Behavioral Phenotype in a Mouse Model of Parkinson’s Disease
    Nina Radisavljevic, Mihai S. Cirstea, Kylynda C. Bauer, Christine Lo, Avril Metcalfe‐Roach, Tahereh Bozorgmehr, Haggai Bar‐Yoseph, B. Brett Finlay · 2022 · Journal of Parkinson s Disease
  44. Leveraging animal models to understand non-motor symptoms of Parkinson's disease
    Thomas Wichmann, Alexandra Nelson, Eileen Ruth S. Torres, Per Svenningsson, Roberta Marongiu · 2025 · Neurobiology of Disease
  45. Anxiety provokes balance deficits that are selectively dopa-responsive in Parkinson’s disease
    Kaylena A. Ehgoetz Martens, Shannon C. Lefaivre, Eric N. Beck, Rebecca Chow, Frederico Pieruccini‐Faria, Colin G. Ellard, Quincy J. Almeida · 2016 · Neuroscience
  46. Pharmacological interventions for anxiety in Parkinson’s disease sufferers
    Hideyuki Sawada, Atsushi Umemura, Masayuki Kohsaka, Satoshi Tomita, Kwiyoung Park, Tomoko Oeda, Kenji Yamamoto · 2018 · Expert Opinion on Pharmacotherapy
  47. “It’s a disease of families”: Neurologists’ insights on how to improve communication and quality of life for families of Parkinson’s disease patients
    Rachel Schwartz, Donna M. Zulman, Caroline P. Gray, Mary Kane Goldstein, RANAK B. TRIVEDI · 2018 · Chronic Illness
  48. Motor fluctuations and psychological distress in Parkinson’s disease.
    Bruce A. Fernie, Marcantonio M. Spada, Richard G. Brown · 2019 · Health Psychology
  49. Altered functional connectivity within the brain fear circuit in Parkinson's disease with anxiety: A seed-based functional connectivity study
    Kaidong Chen, Li Zhang, Feng Wang, Haixia Mao, Qunfeng Tang, Guofeng Shi, Yiping You, Qingfang Yuan, Bixue Chen, Xiangming Fang · 2023 · Heliyon
  50. NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE
    Marina Romanovna Nodel, Nikolay N. Yakhno · 2009 · Neurology neuropsychiatry Psychosomatics
  51. Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics
    Ankur Butala, Melissa D. Shepard, Gregory M. Pontone · 2019 · Handbook of clinical neurology
  52. Predictors of anxiety in Parkinson’s disease: results from a 3-year longitudinal cohort study
    Jessie S. Gibson, Joseph L. Flanigan, James T. Patrie, William Alexander Dalrymple, Madaline B. Harrison · 2022 · Neurological Sciences
  53. Psychiatric Care in Parkinson’s Disease
    Rosa Quelhas · 2013 · Journal of Psychiatric Practice
  54. Is the Parkinson anxiety scale comparable across raters?
    Maria João Forjaz, Alba Ayala, Pablo Martínez‐Martín, Kathy Dujardin, Gregory M. Pontone, SERGIO E. STARKSTEIN, Daniel A. Weintraub, Albert F.G. Leentjens · 2014 · Movement Disorders
  55. Anxiety disorders in older people
    James E. B. Lindesay, Robert J. Stewart, Jatinder Bisla · 2012 · Reviews in Clinical Gerontology
  56. Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease In Long Term Care Settings In The United States
    Sandipan Bhattacharjee, Lisa W. Goldstone, Terri L Warholak · 2016 · Journal of Parkinson s Disease
  57. Supporting self-management in early dementia: a contribution towards ‘living well’?
    Jo Cheffey, Laura Hill, Glenn A. Roberts, Ruth Marlow · 2013 · Advances in Psychiatric Treatment
  58. Drug-induced burning mouth syndrome: a new clinico-pathological entity?
    Giulio Fortuna, Annamaria Pollio · 2012 · The Journal of Headache and Pain
  59. Risk factors for depression in patients with Parkinson’s disease: A nationwide nested case-control study
    Yang‐Pei Chang, Min‐Sheng Lee, Da‐Wei Wu, Jui‐Hsiu Tsai, Pei‐Shan Ho, Chun‐Hung Richard Lin, Hung‐Yi Chuang · 2020 · PLoS ONE
  60. Anxiety in Parkinson’s Disease
    Tanya Simuni, Hubert H. Fernandez · 2012 · Humana Press eBooks
  61. Parkinson’s Disease and Driving Cessation: a Journey Influenced by Anxiety
    Turner, Laura M., Liddle, Jacki, Pachana, Nancy A. · 2017 · Clinical Gerontologist
  62. Excessive Sensitivity to Uncertain Visual Input in L-DOPA-Induced Dyskinesias in Parkinson’s Disease: Further Implications for Cerebellar Involvement
    James K. R. Stevenson, Chonho Lee, Bu‐Sung Lee, Pouria TalebiFard, Edna Ty, Kristina Aseeva, Meeko Oishi, Martin J. McKeown · 2014 · Frontiers in Neurology
  63. Osteoarthritis Increases Paresthestic and Akathisic Pain, Anxiety Case-ness, and Depression Severity in Patients With Parkinson's Disease
    Abdul Qayyum Rana, Abdul Rehman Qureshi, Shakib Akhter, Yameen Ingar, Ayub Ali, Ismael Y. Abdullah, Obaidullah Madhosh, Zainab Sarfraz, Muhammad B. Rana, Ruqqiyah Rana · 2018 · Frontiers in Neurology
  64. The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease
    Siming Jiang, Yongsheng Yuan, Qing Tong, Li Zhang, Qinrong Xu, Jian Ding, Kezhong Zhang · 2015 · Neurological Sciences
  65. Mental Health Diagnoses and Health Care Utilization in Persons With Dementia, Parkinson’s Disease, and Stroke
    Jessica Calleo, Amber Bush Amspoker, Laura Marsh, Mark E. Kunik · 2014 · Journal of Neuropsychiatry
  66. Non-motor Symptoms in Parkinson’s Disease
    Ergun Y. Uc, Jon Tippin, Kelvin L. Chou, Bradley A. Erickson, Kevin C. Doerschug, Decontee M Jimmeh Fletcher · 2012 · European Neurological Review
  67. Social phobia in Parkinson’s disease: Prevalence and risk factors
    fatma betul ozdilek, Engin Emrem Beştepe, Bülent Kadri Gültekin · 2014 · Neuropsychiatric Disease and Treatment
  68. Symptom dimensions of anxiety in Parkinson’s disease: Replication study in a neuropsychiatric patient population
    Sonja Rutten, Erwin E. H. van Wegen, Ires Ghielen, Bridget Schoon, Odile A. van den Heuvel · 2021 · Clinical Parkinsonism & Related Disorders
  69. Parkinsonism
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  70. An Approach to the Patient with Anxiety
    Daniel W. Hicks, Thomas N. Cummings, Steven A. Epstein · 2010 · Medical Clinics of North America
  71. Low frequency deep brain stimulation in the inferior colliculus ameliorates haloperidol-induced catalepsy and reduces anxiety in rats
    Hannah Ihme, Rainer K.W. Schwarting, Liana Melo-Thomas · 2020 · PLoS ONE
  72. Depressive und Angststörungen bei neurologischen Erkrankungen
    H.P. Kapfhammer · 2014 · Der Nervenarzt
  73. Physical activity as a mediator of anxiety and cognitive functioning in Parkinson's disease
    Jacob D. Jones, Holly Timblin, Elizabeth Rahmani, Shania Garrett, Joseph Bunch, Halbert Beaver, Christopher R. Hill · 2021 · Mental health and physical activity
  74. Activation of AMPA Receptors in the Lateral Habenula Produces Anxiolytic Effects in a Rat Model of Parkinson’s Disease
    Jin Zhang, Xiaobing Wang, Rick Eugene Bernardi, Jun Ju, Shoupeng Wei, Zhiting Gong · 2022 · Frontiers in Pharmacology
  75. Rare and unusual dementias
    Susham Gupta, Olivia Fiertag, James P. Warner · 2009 · Advances in Psychiatric Treatment
  76. Diagnosing social anxiety in Parkinson's disease: characteristics and frequencies according to two diagnostic criteria
    Tais Silveira Moriyama, Marcos Hortes Nisihara Chagas, Laura Silveira‐Moriyama, Vítor Tumas, Andrew John Lees, José Alexandre S. Crippa, Rodrigo A. Bressan · 2016 · Archives of Clinical Psychiatry (São Paulo)
  77. Transdiagnostic CBT for Anxiety Disorders
    Terri L. Barrera, Angela Hutchinson Smith, Peter J. Norton · 2014 · Wiley eBooks
  78. Psychische Störungen bei somatischen Krankheiten
    H.P. Kapfhammer · 2011 · Springer eBooks
  79. Lewy Body Degenerations as Neuropsychiatric Disorders
    Jared T. Hinkle, Gregory M. Pontone · 2020 · Psychiatric Clinics of North America
  80. Epidemiology of Psychiatric Symptoms in Parkinson’s Disease
    Albert F.G. Leentjens · 2012 · Advances in biological psychiatry
  81. Psychische Störungen bei somatischen Krankheiten
    Hans‐Peter Kapfhammer · 2017 · Springer eBooks
  82. Maladaptive avoidance patterns in Parkinson’s disease are exacerbated by symptoms of depression
    Jony Sheynin, Irina Baetu, Lyndsey E. Collins‐Praino, Catherine E. Myers, Robyn Winwood-Smith, Ahmed A. Moustafa · 2020 · Behavioural Brain Research
  83. Exploring Nonmotor Neuropsychiatric Manifestations of Parkinson Disease in a Comprehensive Care Setting
    Amitha Dhingra, A. Umair Janjua, Laura M. Hack, Gabriella Waserstein, Justin M. Palanci, Adriana Patricia Hermida · 2020 · Journal of Geriatric Psychiatry and Neurology
  84. Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia
    Nadeeka N. Dissanayaka, Elana J. Forbes, Jihyun Yang, Dana Pourzinal, John D. O’Sullivan, Leander K. Mitchell, David Andrew Copland, Katie Louise McMahon, Gerard J. Byrne · 2021 · Journal of Neurology
  85. Gaps in Treatment for Anxiety in Parkinson Disease
    Justin M. Palanci, Laura Marsh, Gregory M. Pontone · 2011 · American Journal of Geriatric Psychiatry
  86. Familial Aggregation of Panic Disturbances in Parkinson's Disease
    Gregory M. Pontone, Justin M. Palanci, Oscar Joseph Bienvenu, Kung‐Yee Liang, Gerald Nestadt, Peter V. Rabins, James R. Williams, Laura Marsh · 2011 · Journal of Neuropsychiatry
  87. Impact of Progression of Parkinson's Disease and Various Other Factors on Generalized Anxiety Disorder
    Abdul Qayyum Rana, Hamza Ansari, Abdul Rehman Qureshi, Eraad Rahman · 2018 · Journal of Neurosciences in Rural Practice
  88. Troubles psychiques et comportementaux et leurs traitements
    Gilles Fénelon · 2011 · Elsevier eBooks
  89. Interventional magnetic resonance imaging-guided subthalamic nucleus deep brain stimulation for Parkinson′s disease: Patient selection
    Hooman Azmi, Fiona Gupta, Mario Vukic, Jason Kreitner, Elizabeth C. Kera, Gregory N. Nicola, Sean D. Pierce, David Panush, Randy E. Cohen · 2016 · Surgical Neurology International
  90. Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches
    Neha Mathur, Haseel Bhatt, Sarah C. Lidstone · 2022 · Seminars in Neurology
  91. Development and Validation of a Prediction Model for Anxiety Improvement after Deep Brain Stimulation for Parkinson Disease
    Bowen Chang, Jiaming Mei, Ni Chen, Chi Xiong, Peng Chen, Manli Jiang, Chaoshi Niu · 2023 · Brain Sciences
  92. Palliative care for patients with Parkinson’s disease: an interdisciplinary review and next step model
    Kimmy Su, Julie Carter, Keiran K. Tuck, Tony Borcich, Linda Bryans, Lisa Mann, Jennifer L. Wilhelm, Erik K. Fromme · 2017 · Journal of Parkinsonism and Restless Legs Syndrome
  93. Investigating affective neuropsychiatric symptoms in rodent models of Parkinson’s disease
    Laura Boi, Gilberto Fisone · 2023 · International review of neurobiology
  94. Neuropsychology of Movement Disorders and Motor Neuron Disease
    Alexander I. Tröster, Steven Paul Woods · 2010 · Springer eBooks
  95. Prevalence, impact, and management of depression and anxiety in patients with Parkinson’s disease
    Jenna B. Renfroe, Travis H. Turner, Vanessa K. Hinson · 2016 · Journal of Parkinsonism and Restless Legs Syndrome
  96. Therapeutic Group Singing for Individuals with Parkinson’s Disease: A Conceptual Framework
    Sun Joo Lee, Abbey Lynn Dvorak · 2023 · Music Therapy Perspectives
  97. Psychiatric morbidity in patients with idiopathic Parkinson's disease
    Santhosh Kumar, Ajit Avasthi, Manish Modi, Sandeep Grover · 2021 · Industrial Psychiatry Journal
  98. The association between restless leg syndrome and anxiety in Parkinson’s disease: a case-control study
    Lvming Zhang, Zhirong Wan, Xiaobo He, Lixia Cheng, Peifu Wang, Jilai Li, Jichen Du · 2021 · Neurological Research
  99. Anxiety and its impact on quality of life among urban elderly population in India: An exploratory study
    Kathika Chattopadhyay, AnandPratap Singh · 2016 · Indian Journal of Research in Homoeopathy
  100. Sex differences in behavioral measures of anxiety in a recessive gene knockout (Pink1–/–) rat model of Parkinson’s disease
    Sharon Feehan, Mary F. Kritzer · 2025 · Frontiers in Behavioral Neuroscience